1-(1-acetyl-1,2,3,4-tetrahydroquinolin-6-yl)-2-(3-bromophenyl)ethane-1,2-dione | 937594-23-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-(1-acetyl-1,2,3,4-tetrahydroquinolin-6-yl)-2-(3-bromophenyl)ethane-1,2-dione
• 英文别名: 1-(1-acetyl-3,4-dihydro-2H-quinolin-6-yl)-2-(3-bromophenyl)ethane-1,2-dione
• CAS: 937594-23-5
• 化学式: C₁₉H₁₆BrNO₃
• 分子量: 386.245
• InChiKey: BFCUHJHFVMSEDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  54.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
  申请人：Berg Stefan

  公开号：US20090233930A9

  公开（公告）日：2009-09-17

  This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

  本发明涉及具有以下结构式I的新化合物，以及它们的药学上可接受的盐、组合物和使用方法。这些新化合物提供了治疗或预防认知障碍、阿尔茨海默病、神经退行性和痴呆症的方法。
• POTENT PARP INHIBITORS
  申请人：Penning Thomas D.

  公开号：US20090298858A1

  公开（公告）日：2009-12-03

  The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I), their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.

  本发明涉及公式（I）的1H-苯并咪唑-4-羧酰胺，它们的制备以及它们作为聚（ADP-核糖）聚合酶酶的抑制剂用于药物制备的用途。
• Potent PARP Inhibitors
  申请人：Penning D. Thomas

  公开号：US20080015182A1

  公开（公告）日：2008-01-17

  The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I), their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.

  本发明涉及式(I)的1H-苯并咪唑-4-羧酰胺化合物，其制备以及它们作为聚(ADP-核糖)聚合酶酶的抑制剂用于制备药物。
• NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA
  申请人：Astra Zeneca AB

  公开号：EP1979324A2

  公开（公告）日：2008-10-15
• US8183250B2
  申请人：——

  公开号：US8183250B2

  公开（公告）日：2012-05-22